3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
3
Thoracic
1
Head & Neck
1
CNS
1
Conditions
Lung Neoplasms
102
Carcinoma, Non-Small-Cell Lung
84
Breast Neoplasms
16
Neoplasm Metastasis
14
Melanoma
14
Brain Neoplasms
14
Small Cell Lung Carcinoma
13
Esophageal Neoplasms
10
Colorectal Neoplasms
9
Carcinoma, Renal Cell
9
Pancreatic Neoplasms
8
Ovarian Neoplasms
8
Adenocarcinoma of Lung
8
Prostatic Neoplasms
7
Carcinoma, Hepatocellular
7
Colonic Neoplasms
6
Stomach Neoplasms
5
Carcinoma, Transitional Cell
5
Uterine Cervical Neoplasms
4
Triple Negative Breast Neoplasms
4
Thyroid Neoplasms
4
Sarcoma, Kaposi
4
Rectal Neoplasms
4
Meningeal Carcinomatosis
4
Squamous Cell Carcinoma of Head and Neck
3
Neoplasms
3
Lymphoma
3
Head and Neck Neoplasms
3
HIV Infections
3
Carcinoma, Medullary
3
Interventions
Tomography, X-Ray Computed
2
Hematologic Tests
2
Blood Specimen Collection
2
tivozanib
1
pembrolizumab
1
aflibercept
1
Videotape Recording
1
Urination
1
Thoracoscopy
1
Thoracic Surgical Procedures
1
Sulfonylurea Compounds
1
Sodium-Glucose Transporter 2 Inhibitors
1
Referral and Consultation
1
Octreotide
1
Magnetic Resonance Spectroscopy
1
Lymph Node Excision
1
Ipilimumab
1
Interviews as Topic
1
Interleukin-15
1
In Situ Hybridization
1
Immunohistochemistry
1
Exercise
1
Erlotinib Hydrochloride
1
Equipment and Supplies
1
Educational Status
1
Dipeptidyl-Peptidase IV Inhibitors
1
Diagnostic Tests, Routine
1
Diagnosis
1
Clinical Laboratory Techniques
1
Bupivacaine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Disease
×
Magnetic Resonance Spectroscopy
×
Thoracic
×
Clear all
NCT00136890
2013-01-15
ELPET
Ontario Clinical Oncology Group (OCOG)
Phase 3
Completed
337 enrolled